Literature DB >> 17283250

High blood pressure in pregnancy and coronary calcification.

Siamak Sabour1, Arie Franx, Annemarieke Rutten, Diederick E Grobbee, Mathias Prokop, Marie-Louise Bartelink, Yvonne T van der Schouw, Michiel L Bots.   

Abstract

A considerable proportion of pregnant women develop high blood pressure in pregnancy. Although it is assumed that this condition subsides after pregnancy, many of these women develop the metabolic syndrome later in life and are at increased risk to develop coronary heart disease. Atherosclerosis development is considered in between risk factors and occurrence of vascular symptoms. We set out to cross-sectionally study the relation of high blood pressure during pregnancy with risk of coronary calcification. The study population was composed 491 healthy postmenopausal women selected from a population-based cohort study. Information on high blood pressure during pregnancy was obtained using a questionnaire. Between 2004 and 2005, the women underwent a multidetector computed tomography (Philips Mx 8000 IDT 16) to assess coronary calcium. The Agatston score, volume, and mass measurements were used to quantify coronary calcium. A total of 30.7% of the women reported to have had high blood pressure in pregnancy. Body mass index (odds ratio [OR]: 1.05; 95% CI: 1.01 to 1.09) and diastolic blood pressure (OR: 1.03; 95% CI: 1.01 to 1.05) were significantly related to a history of high blood pressure in pregnancy. Age was significantly related to increased coronary calcification. Women with a history of high blood pressure during pregnancy had a 57% increased risk of having coronary calcification compared with those women without this condition (OR: 1.57; 95% CI: 1.04 to 2.37). After adjusting for age, the relation did not change (OR: 1.64; 95% CI: 1.07 to 2.53). We concluded that high blood pressure during pregnancy is associated with an increased risk of coronary calcification later in life.

Entities:  

Mesh:

Year:  2007        PMID: 17283250     DOI: 10.1161/01.HYP.0000258595.09320.eb

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  13 in total

1.  IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?

Authors:  Babbette Lamarca; Justin Brewer; Kedra Wallace
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2011-07-01

2.  The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2010-04

Review 3.  Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Authors:  Babbette D LaMarca; Jeffery Gilbert; Joey P Granger
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

4.  Study of the molecular variation in pre-eclampsia placenta based on micro-Raman spectroscopy.

Authors:  Si-Jin Chen; Yuan Zhang; Xiang-Ping Ye; Kun Hu; Mei-Fang Zhu; Yan-Yue Huang; Mei Zhong; Zheng-Fei Zhuang
Journal:  Arch Gynecol Obstet       Date:  2014-05-28       Impact factor: 2.344

5.  A history of preeclampsia is associated with a risk for coronary artery calcification 3 decades later.

Authors:  Wendy M White; Michelle M Mielke; Philip A Araoz; Brian D Lahr; Kent R Bailey; Muthuvel Jayachandran; Virginia M Miller; Vesna D Garovic
Journal:  Am J Obstet Gynecol       Date:  2016-02-10       Impact factor: 8.661

6.  Hypertension during pregnancy is associated with coronary artery calcium independent of renal function.

Authors:  Andrea E Cassidy-Bushrow; Lawrence F Bielak; Andrew D Rule; Patrick F Sheedy; Stephen T Turner; Vesna D Garovic; Patricia A Peyser
Journal:  J Womens Health (Larchmt)       Date:  2009-10       Impact factor: 2.681

7.  Cardiovascular risk in women after metabolic complications in pregnancy.

Authors:  A H E M Maas; A W J van 't Hof; M J de Boer
Journal:  Neth Heart J       Date:  2007-12       Impact factor: 2.380

8.  Cardiovascular risk factor assessment after pre-eclampsia in primary care.

Authors:  Marie-Elise Nijdam; Monique R Timmerman; Arie Franx; Hein W Bruinse; Mattijs E Numans; Diederick E Grobbee; Michiel L Bots
Journal:  BMC Fam Pract       Date:  2009-12-08       Impact factor: 2.497

9.  Cardiovascular RiskprofilE - IMaging and gender-specific disOrders (CREw-IMAGO): rationale and design of a multicenter cohort study.

Authors:  Gerbrand A Zoet; Cindy Meun; Laura Benschop; Eric Boersma; Ricardo P J Budde; Bart C J M Fauser; Christianne J M de Groot; Aad van der Lugt; Angela H E M Maas; Karl G M Moons; Jeanine E Roeters van Lennep; Jolien W Roos-Hesselink; Eric A P Steegers; Bas B van Rijn; Joop S E Laven; Arie Franx; Birgitta K Velthuis
Journal:  BMC Womens Health       Date:  2017-08-07       Impact factor: 2.809

10.  Electrocardiogram abnormalities and coronary calcification in postmenopausal women.

Authors:  Siamak Sabour; Diederick Grobbee; Annemarieke Rutten; Mathias Prokop; Marie-Louise Bartelink; Yvonne van der Schouw; Michiel Bots
Journal:  J Tehran Heart Cent       Date:  2010-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.